Press Release: Penn team identifies promising new target for gum disease treatment

“University of Pennsylvania researchers have been searching for ways to prevent, halt and reverse periodontitis. In a report published in The Journal of Immunology, they describe a promising new target: a component of the immune system called complement. Treating monkeys with a complement inhibitor successfully prevented the inflammation and bone loss that is associated with periodontitis, making this a promising drug for treating humans with the disease.”

To read entire press release: